Transaction · 0001610717-26-000392

Saxonov Serge

Saxonov Serge, CEO, reported an open-market or private sale at 10x Genomics, Inc. involving 18545.000000 shares for an estimated $1168774.52. Reported holdings after the transaction were 1085835.000000 shares. A 10b5-1 reference was not detected in the stored filing text.

Open-market sellSEC transaction code SCEO
TXG10x Genomics, Inc.
Trade date
Aug 24, 2026
Filing date
Aug 26, 2026
View on SEC Insider profile
Estimated value-$1.16MShares × reported price
Shares traded18.5k$63.02 per share
Holdings after1.08MDirect
% of reported position traded1.68%This security and ownership context
How reported position traded is calculated

Shares sold ÷ (holdings after + shares sold). Estimated position before: 1,104,380 shares.

Row-level estimate for this security and ownership context, not the insider’s complete portfolio. Joint ownership, other transactions in the filing, amendments and footnotes can affect interpretation.

TXG price since this filing

Daily closing prices, with the filing date and available return windows
TXG · Daily closing priceLoading daily prices…
Filing dateReturn windows appear as prices become available.
Pre-filing1mo ago -28.0%1w ago -9.8%1d ago +1.3%
Returns since7d -4.1%30d +33.4%90d180d1y

Transaction facts

Stored Form 4 columns with their raw values

Non-derivative
Type
Sell
Code S
Identifier
0001610717-26-000392
Class A Common Stock
Transaction date
Aug 24, 2026
Filed Aug 26, 2026, 08:46 PM · 2d delay
Shares
18,545 sh
$63.02 per share
Estimated value
-$1.16M
Computed from shares × price
Holdings after
1,085,835 sh
Direct

Filing signal explanations

Badges describe filing facts only — not predictions.

Cluster 14dRepeat 30dPattern $100kLarge $1.00M
Cluster Selling Direct Ownership Large Sale
Filing-only score

+10 points

Compact filing score computed from stored Form 4 facts. Version v1.

Positive filing signal

This filing has a modest positive filing-only score. Treat it as a useful flag for review, not as a buy signal.

How this score is calculated
  • direct_ownership+6 points

    direct_or_indirect_ownership = D

    Direct ownership reports the insider's personal stake.
  • timely_filing+4 points

    reporting_delay_days = 2

    Filing reported within two business days of the transaction.
Read the scoring methodology

Signed filing-only points, not a probability or expected return. Version v1.

Reported relationships & other filings

Form 4 relationship flags and nearby filing context

Reported roles

Chief Executive Officer

Officer YesDirector Yes10% NoOther No
Footnotes & amended
  1. F1

    The shares were sold to cover tax withholding obligations in connection with the vesting of restricted stock units.

  2. F2

    This transaction was executed in multiple trades at prices ranging from $63.0088 to $63.78, inclusive. The price reported above reflects the weighted average sale price. The Reporting Person undertake…

  3. F3

    The shares are held by the Andromeda Trust, for which the Reporting Person serves as trustee.

  4. F4

    The shares are held by the Y/S Descendants' Trust, for which the Reporting Person serves as trustee.

  5. F5

    The shares are held by the Y/S Pot Trust, for which the Reporting Person serves as trustee.

Original filing · 0001610717-26-000392
Related transactions

0 other transactions

Same SEC filing
Recent company activity

0 recent txs

TXG